Study Finds Robots can Detect Breast Cancer as well as Radiologists

Breast cancer is the most common cancer in women, and despite important improvements in therapy, it is still a major cause for cancer-related mortality, accounting for approximately 500,000 annual deaths worldwide. Breast cancer screening programs using mammography are effective in reducing breast cancer-related mortality. However, current screening programs are highly labor intensive due to the large number of women that have to be screened. Considering the increasing scarcity of breast screening radiologists in some countries, many researchers believe other screening methods may be worth investigating.

A new paper in the Journal of the National Cancer Institute suggests that artificial intelligence systems may be able to perform as accurately as radiologists in the evaluation of digital mammography in breast cancer screening.

Since the 1990s, computer-aided detection systems have been developed to detect and classify breast lesions in mammograms automatically. However, no studies to date have found that these systems directly improve screening performance or cost effectiveness. This has precluded their use as a method for screening mammography.

In this study researchers compare, at a case level, the cancer detection performance of a commercially available AI system to that of 101 radiologists who scored nine different cohorts of mammography examinations from four different manufacturers as part of studies previously performed for other purposes.

Each dataset consisted of mammography exams acquired with systems from four different vendors, multiple radiologists' assessments per exam, yielding a total of 2,652 exams (653 malignant) and interpretations by 101 radiologists (28,296 independent interpretations).

The performance of the artificial intelligence system was statistically not-inferior to that of the average of the 101 radiologists. The evaluated system achieved a cancer detection accuracy comparable to an average breast radiologist in this retrospective setting.

"Before we could decide what is the best way for AI systems to be introduced in the realm of breast cancer screening with mammography, we wanted to know how good can these systems really be," said Ioannis Sechopoulos, one of the paper's authors. "It was exciting to see that these systems have reached the level of matching the performance of not just radiologists, but of radiologists who spend at least a substantial portion of their time reading screening mammograms."

Alejandro Rodriguez-Ruiz, Kristina Lång, Albert Gubern-Merida, Mireille Broeders, Gisella Gennaro, Paola Clauser, Thomas H Helbich, Margarita Chevalier, Tao Tan, Thomas Mertelmeier, Matthew G Wallis, Ingvar Andersson, Sophia Zackrisson, Ritse M Mann, Ioannis Sechopoulos.
Stand-Alone Artificial Intelligence for Breast Cancer Detection in Mammography: Comparison With 101 Radiologists.
JNCI: Journal of the National Cancer Institute, djy222. doi: 10.1093/jnci/djy222.

Most Popular Now

MEDICA 2024 + COMPAMED 2024: Adapted Hal…

11 - 14 November 2024, Düsseldorf, Germany. The final preparations for MEDICA 2024 and COMPAMED 2024 in Düsseldorf have begun. A total of more than 5,500 exhibitors from approximately 70 countries...

AI does Not Necessarily Lead to more Eff…

The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long...

Commission Joins Forces with Venture Cap…

The Commission has launched a Trusted Investors Network bringing together a group of investors ready to co-invest in innovative deep-tech companies in Europe together with the EU. The Union's investment...

An AI-Powered Pipeline for Personalized …

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses...

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

AI could Transform How Hospitals Produce…

A pilot study led by researchers at University of California San Diego School of Medicine found that advanced artificial intelligence (AI) could potentially lead to easier, faster and more efficient...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

New Research Shows Promise and Limitatio…

Published in JAMA Network Open, a collaborative team of researchers from the University of Minnesota Medical School, Stanford University, Beth Israel Deaconess Medical Center and the University of Virginia studied...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...